News | May 25, 2022
Johnson & Johnson and Momenta Pharmaceuticals file lawsuit against NATCO Pharma
This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner Mylan
This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner Mylan
Novel tool bypasses plasmid-based expression to increase stability and significantly reduce development time for a variety of synthetic biotechnology products
The panel is headed by DCGI Dr VG Somani with representatives from various state drug regulators and health ministry
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Move amid evidence of widespread reporting gaps
The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students
Interchangeable biosimilars to Prolia and Xgeva target osteoporosis and cancer-related bone complications in a $5 billion U.S. market
Subscribe To Our Newsletter & Stay Updated
